# William Hendren

> William G. Hendren, MD, MBA is the co-founder and CEO of QURA, Inc., a Duxbury, Massachusetts medical technology company building the QSmart platform - an implantable biosensor roughly the size of a grain of rice that continuously measures and wirelessly transmits medical-grade blood pressure data in real time. A surgeon trained at Harvard, Mass General, Emory and the Cleveland Clinic, with an MBA and strategic healthcare consulting experience at PwC across the US, Middle East, China and the UK, Hendren is taking aim at hypertension, which he calls the single leading healthcare threat in the world.

- **Role:** Co-Founder and Chief Executive Officer at QURA, Inc.
- **Organizations:** QURA, Inc., PwC
- **Nationality:** American
- **Education:** Undergraduate, graduated summa cum laude, Dartmouth College, MD, Harvard Medical School, MBA, Marshall School of Business, University of Southern California, General and cardiac surgical training, Massachusetts General Hospital (Harvard), Surgical training, Emory University, Specialized cardiac surgical training, Cleveland Clinic
- **Known for:** Co-founded QURA, Inc. and developed the QSmart implantable biosensor platform for continuous blood-pressure monitoring, Assembled an advisory board including Cleveland Clinic former CEO Delos Cosgrove and Intuitive Surgical co-founders John Freund and Frederick Moll, Graduated summa cum laude from Dartmouth College

## Career timeline

- **—** — Trained as a general and cardiac surgeon at Massachusetts General Hospital, Emory University and the Cleveland Clinic
- **—** — Held leadership roles in cardiovascular surgery across multinational and startup companies
- **—** — Strategic healthcare consultant at PwC, advising on projects across the US, the Middle East, China and the UK
- **2018** — QURA receives a $1 million strategic Series A investment from Santen Ventures to support the QSmart wireless measurement platform
- **2024** — Presents QURA's continuous blood-pressure technology at LSI USA '24; company preparing first-in-human feasibility studies in Australia
- **—** — Leading QURA as CEO toward FDA submission and early commercialization of the QSmart hypertension platform

## Achievements

- Co-founded QURA, Inc. and developed the QSmart implantable biosensor platform for continuous blood-pressure monitoring
- Assembled an advisory board including Cleveland Clinic former CEO Delos Cosgrove and Intuitive Surgical co-founders John Freund and Frederick Moll
- Graduated summa cum laude from Dartmouth College
- Built and executed large-scale healthcare projects internationally, including establishing healthcare facilities abroad

## Latest updates

- **2024-03** — Presented QURA's continuous blood-pressure data platform at LSI USA '24, outlining plans for first-in-human feasibility studies in Australia and a path to FDA submission.

## Links

- Website: https://qura-med.com
- LinkedIn: http://www.linkedin.com/in/willhendren
- YouTube: https://www.youtube.com/watch?v=GfPr4IzLGew

---

Profile page: https://yespress.io/william-hendren
Published by YesPress — https://yespress.io
Last updated: 2026-06-04